Related Experiment Videos
Neuroinflammation in Parkinson's disease
Etienne C Hirsch1, Sheela Vyas, Stéphane Hunot
1INSERM, UMR_S975, CRicm, Experimental Therapeutics of neurodegeneration, F-75013, Paris, France. etienne.hirsch@upmc.fr
Parkinsonism & Related Disorders
|December 15, 2011
Summary
Neuroinflammation plays a key role in Parkinson's disease (PD) progression, driving neuronal death. Targeting these inflammatory processes, particularly microglial reactivity via glucocorticoid receptors, may offer neuroprotection for PD patients.
Area of Science:
- Neuroscience
- Immunology
- Pathophysiology
Background:
- Epidemiological and genetic studies implicate neuroinflammation in Parkinson's disease (PD).
- Post-mortem analyses reveal innate and adaptive immune system involvement in PD-affected brain regions.
- Activated microglia and T lymphocytes, along with elevated pro-inflammatory mediators, are observed in the substantia nigra of PD patients.
Purpose of the Study:
- To explore the role of neuroinflammation in Parkinson's disease pathogenesis.
- To investigate the contribution of inflammatory processes to neuronal degeneration in PD.
- To identify potential neuroprotective strategies targeting neuroinflammation in PD.
Main Methods:
- Review of epidemiological, genetic, and post-mortem studies in human PD patients.
- Analysis of preclinical data from animal models of PD.
- Examination of the role of glucocorticoid receptors in regulating microglial activity.
Main Results:
- Neuroinflammation is implicated in the self-perpetuating degeneration of neurons in PD.
- Inflammatory processes contribute to neuronal cell death, though not as the primary cause.
- Glucocorticoid receptor activity is crucial for controlling microglial reactivity; its deregulation can sustain inflammation-mediated degeneration.
Conclusions:
- Neuroinflammatory processes are integral to the pathophysiology and progression of Parkinson's disease.
- Targeting neuroinflammation, potentially through modulation of glucocorticoid receptor pathways, represents a promising therapeutic avenue for neuroprotection in PD.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...